< Practice Enhancement Programs / Slide Kits

Welcome to the Canadian Heart Research Centre's slide kit download section of our website. Browse through the topics below and select (click) the title to begin downloading the corresponding files. The files will either be in PDF or PowerPoint format.

Evolving Concepts for Cholesterol Absorption Inhibition and Vascular Risk Reduction

David Fitchett, MD

Management of the Cardiovascular Patient in Your Office - 2007
	The Role of ACE-I: Managing risk across the CV continuum	David Fitchett, MD
	Managing ACS Patients: Importance of dual antiplatelet therapy	Robert Welsh, MD
	How Low Do We Go and How Do We Achieve Aggressive Goals?	Gabor Gyenes, MD
	Evolution of Statin Trials On Vulnerable Plaque	Robert Welsh, MD
Management of Risk Factors
	Evidence Supporting the CCS and CDA Dyslipidemia Guidelines	Anatoly Langer, MD
	Overview of Smoking Cessation in Canada	Charl Els, MD
	3 Minute Empowerment: How to motivate your patient to change any behaviour	Nigel Flook, MD
	Optimal Management in the Treatment of Global Cardiovascular Risk: Result of ASCOT 2x2	Anatoly Langer, MD
New Targets in Outpatient Practice
	Better BP Control: The earlier the better	Kailash Jindal, MD
	Innovations in Hypertension Management:  Direct rennin inhibition	David Fitchett, MD
	Exploration of Landmark CV Trials: HOPE to ONTARGET	Kailash Jindal, MD
	The ABC's of ARB's for Hypertension	Zaheer Lakhani, MD

Advances in Therapy
	Diabetic Nephrophathy: What every physician needs to know	Stuart Ross, MD
	Comprehensive Approach to Metabolic Improvement	Lawrence Leiter, MD
	Insulin Delivery - Can we do better?	Stuart Ross, MD
	Importance of Reaching an LDL Goal in Diabetic Patients	Greg Bondy, MD
State of the Art in Diabetes Management
	Update on Glycemic Control: Care gap	Lawrence Leiter, MD
	Can We Stop the Progression of Diabetes: DREAM	Greg Bondy, MD
	ADOPT: Are all hypoglycemic agents the same?	Stuart Ross, MD
Improving Outcomes in Everyday Practice
	Incretin Hormones: Relevance to clinical management of diabetes	Breay Paty, MD
	Advances in Oral Therapy	Lawrence Leiter, MD
	Cardiovascular Risk Stratification in Patients with Type 2 Diabetes	David Fitchett, MD

I - New Strategies in High Risk Prevention
	Implications of the Evidence-Based Canadian Obesity Clinical Practice Guidelines to the Practicing Cardiologist	David Lau
	Aggressive Interventions: From pre-diabetes to diabetes - The role of rosiglitazone	Amir Hanna
	Global Risk Assessment:  The New Math 1+1 = 4 !	Beth Abramson
	The Who, When and How of Imaging in the High Risk Asymptomatic Patient	Michael Freeman
III What to do When the Plaque Ruptures Chair: Robert Chisholm
	The Acute Coronary Syndrome (ACS) Top Ten	Shaun Goodman
	DES: Benefit or Hazard	Michael Kutryk
	The Risk-Management Paradox: Are we really selecting the right patients?	Andrew Yan
IV - Improving Outcomes in Complex patients Chair:Howard Leong-Poi
	Acute Heart Failure: New Evidence, New Guidelines	Gordon Moe
	Devices for Dummies	Victoria Korley
	What’s new in Hypertension?	Juan Carlos Monge
	The Chronic Vascular Disease Management Marketplace: But who is ihe investor?	David Alter
V - Debate Chair:Thomas Parker
	A Cardiologist’s Perspective: NSAID’s, including COX-2 inhibitors, are not safe	Protagonist: David Fitchett
		Antagonist: Anatoly Langer